Hope for HIE – Hypoxic Ischemic Encephalopathy Hope for HIE – Hypoxic Ischemic Encephalopathy

BLOG

Rosemary Kennedy: The Legacy of HIE, Autism, and a Movement for Inclusion, Research, and Hope

April 18th, 2025  | Advocacy  | News

 

When we talk about the roots of today’s HIE advocacy and research in the United States and wtih NIH funding, we turn to the story of Rosemary Kennedy—a young woman whose life forever changed her, her family, and in turn, the world.

Born in 1918, Rosemary was the third child of Joseph and Rose Kennedy. Many experts believe Rosemary experienced a neonatal brain injury consistent with Hypoxic-Ischemic Encephalopathy (HIE)—a lack of oxygen to the brain around the time of birth. Today, we know that HIE occurs in approximately 2.5 per 1,000 live births in the U.S. and can lead to a range of outcomes, including physical and intellectual disabilities, epilepsy, and neurodevelopmental conditions such as autism.

It’s now also believed that Rosemary may have had autism related to her HIE. However, in the early 20th century, society lacked the understanding, acceptance, and resources we have today. After a failed lobotomy pushed by her family in her twenties, in an attempt to mitigate behavioral and cognitive concerns, Rosemary spent much of her life in institutional care, away from the public. The lobotomy caused severe disabilities, rendering her without a voice, and unable to walk.

Her sister, Eunice Kennedy Shriver, was determined to change the narrative. Inspired by Rosemary’s experience, Eunice founded the Special Olympics in 1968—a revolutionary act that promoted the dignity, potential, and inclusion of people with intellectual and developmental disabilities around the world.

In parallel, the Kennedy family’s advocacy led to the creation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in 1962, part of the National Institutes of Health. NICHD has been a global leader in research on pregnancy outcomes, child development, and infant brain injuries—including HIE.

One of NICHD’s most groundbreaking efforts was the multicenter clinical trial on therapeutic hypothermia, led by Dr. Seetha Shankaran. This research, conducted through the NICHD Neonatal Research Network (NRN), demonstrated that cooling babies with moderate or severe HIE could significantly reduce death and disability. This study changed the global standard of care and continues to impact lives every day.

Today, Hope for HIE, the global patient advocacy organization for families facing neonatal and pediatric-acquired HIE, is continuing this legacy. As a community partner of the NICHD Neonatal Research Network, Hope for HIE proudly serves on the NRN Community Engagement Panel, ensuring that research priorities reflect the lived experiences and voices of the HIE community, encouraging further research to be funded through NRN/NICHD/NINDS/NIH.

As we recognize HIE Awareness Month and Autism Acceptance Month, and at a time when harmful public rhetoric is resurfacing that devalues and disparages the autism and disability community, educating and elevating stories like Rosemary Kennedy’s is more important than ever. Her life—and the powerful ripple effect it created from a horrific, life-altering medical decision—reminds us how far we’ve come, and how much more we must do to promote understanding, inclusion, and equity in both medical research and society at large.

With 2025's HIE Awareness Month theme of Hope in Action, we encourage our community to advocate for protecting, funding and advancing research for HIE worldwide.

 

SIGNUP

Connect with families, read inspiring stories, and get helpful resources delivered right to your inbox.

  • This field is for validation purposes and should be left unchanged.